SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
PharmAthene, Inc. Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine